Nanodrug with ROS and pH Dual‐Sensitivity Ameliorates Liver Fibrosis via Multicellular Regulation

Nanodrug with ROS and pH Dual‐Sensitivity Ameliorates Liver Fibrosis via Multicellular Regulation

Abstract Liver fibrosis currently represents a global health problem without effective pharmacotherapeutic strategies. The clinical translation of polydatin, a promising natural anti‐fibrotic drug candidate with broad anti‐inflammatory and antioxidant capabilities, remains a major challenge due to i...

Full description

Bibliographic Details
Main Authors: Liteng Lin, Hengye Gong, Rui Li, Jingjun Huang, Mingyue Cai, Tian Lan, Wensou Huang, Yongjian Guo, Zhimei Zhou, Yongcheng An, Zhiwei Chen, Licong Liang, Yong Wang, Xintao Shuai, Kangshun Zhu
Format: Article
Language:English
Published: Wiley 2020-04-01
Series:Advanced Science
Subjects:
liver fibrosis
liver‐targeting delivery
microenvironment sensitive
multicellular regulation
nanodrugs
Online Access:https://doi.org/10.1002/advs.201903138

Internet

https://doi.org/10.1002/advs.201903138

Similar Items